"As the World's 3rd Largest Pharmaceutical company, and the World's 3rd Largest Oral Healthcare company chose to work with OBJ Limited as its Technology Partner in the field of Oral Healthcare in 2010, does this not in fact confirm that GSK may not be referenced at all among the list of those in 2012 who chose to work with OBJ as their Technology Partner?"
Fair call. I missed that possibility. So you reckon page 4 of the AGM presentation was a list of companies who began in 2012 to "work with OBJ as their technology partner"? Okay, then what does "technology partner" mean? What kind of agreement? Asking OBJ to test? OBJ offering to test? It's pretty vague. Did all these companies sign agreements without OBJ announcing them properly? And did Pfizer allow OBJ to mention them in this way? That suggests the relationship would be either insignificant or the confidentiality is not strong, yet your trumpeting of Pfizer makes it look like a solid relationship, as if the deal is done. In fact, you mention "another global collaboration partnership" and list it on equal footing with the GSK partnership.
Also, why are scientists listed as "companies [who] chose to work with OBJ as their technology partner"? Is it because some scientists have ABN numbers and therefore can be called "companies"? Did they only start working with OBJ in 2012? Really, I think that AGM presentation was rough and therefore unreliable. The fact that you take it as gospel and treat Pfizer as definite and on equal footing with GSK suggests that you are not being objective re OBJ and management. But, of course, it's your choice.
amg63,
"abdm as a respected poster and as was mentioned before I request with respect that you please don't reply to MG..."
I am surprised that you and abdm are not embarrassed by this begging. We're all here to help each other be clear about OBJ. If you want to stay objective about your investments, you should want people to question beliefs. You should be keen for that.
"he does no research and rebuts simply off the knowledge that you and the many posters on HC have given him.
You keep repeating this lie, hoping it will stick, and some others don't call you out on it because they aren't interested in the truth. Fair enough, this is an internet forum so standards are low. I guess you probably felt offended when I have previously pointed out errors in your reasoning, but don't take it personally. It's just trying to keep things clear about the stock. I also pointed out that you dropped a bombshell regarding PNO and then avoided follow-up questions in the thread below. Again, don't take it personally. You made a huge claim, so naturally I am interested in seeing your evidence and getting clear about it. People have been suggesting that Tripeptofen is going to be a global blockbuster for OBJ, a new paradigm in pain treatment, but now you are saying that Glynn said there's no relationship with OBJ. That's a huge issue regarding people's investments, so it needs to be sorted out. BTW, abdm thinks you are wrong re PNO. Here's the thread, awaiting your response:
Don't worry, I'm not encouraged at all. Rather, I am mostly repelled. The response to this CR is so telling, especially when added to the bizarre attacks on me since I first raised concerns about this own patch programme when it was originally announced. Seems that some people have no ability for sober reassessment after news goes against their claims/expectations/dreams.
OBJ Price at posting:
1.5¢ Sentiment: LT Buy Disclosure: Not Held
(20min delay)